Results 1 to 10 of about 158,744 (119)

The Relationship between Pathological Features and 18F-FDG PET/CT that Changed the Surgeon's Decision as Neoadjuvant Therapy in Breast Cancer

World Journal of Nuclear Medicine, 2022
Objective Patients diagnosed with breast cancer and decided to undergo surgical treatment can undergo neoadjuvant therapy following their 2-deoxy-2-[fluorine-18]fluoro-D-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) findings ...
Akay Edizsoy, Ahmet Dağ, Pınar Pelin Özcan, Zehra Pınar Koç   +3 more
doaj   +1 more source

Relationship of dose to vascular target volumes and local failure in pancreatic cancer patients undergoing neoadjuvant chemoradiation

Frontiers in Oncology, 2022
ObjectiveThe objectives of this study were to evaluate whether dose to the vasculature is associated with local control after surgery in patients with borderline resectable (BLR) and resectable pancreatic cancer (PCA) receiving neoadjuvant radiation ...
Bailey Nelson, Michelle Barrord, Kyle Wang, Nolan A. Wages, Nolan A. Wages, Mickaela Sudhoff, Jordan Kharofa   +6 more
doaj   +1 more source

Efficacy and safety of neoadjuvant immunotherapy combined with chemoradiotherapy or chemotherapy in esophageal cancer: A systematic review and meta-analysis

Frontiers in Immunology, 2023
BackgroundSignificant progress has been made in the investigation of neoadjuvant immune-chemoradiotherapy (NICRT) and neoadjuvant immune-chemotherapy (NICT) on the outcomes of esophageal cancer patients.
Yunsong Liu, Yongxing Bao, Xu Yang, Shuang Sun, Meng Yuan, Zeliang Ma, Wanting Zhang, Yirui Zhai, Yang Wang, Yu Men, Jianjun Qin, Liyan Xue, Jun Wang, Zhouguang Hui   +13 more
doaj   +1 more source

Neoadjuvant Nivolumab and Ipilimumab for Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus [PDF]

Journal of Immunotherapy and Precision Oncology, 2023
Renal cell carcinoma with level IV tumor thrombus is a condition necessitating aggressive surgical management. Many solid organ malignancies often benefit from neoadjuvant treatments for tumor debulking and improvement of surgical outcomes.
Viraj A. Master, Benjamin N. Schmeusser, Adeboye O. Osunkoya, Arnold R. Palacios, Eric Midenberg, Lauren Yantorni, Kenneth Ogan, Mehmet A. Bilen   +7 more
doaj   +1 more source

Merkel Cell Carcinoma: An Immunotherapy Fairy-Tale?

Frontiers in Oncology, 2021
Merkel cell carcinoma (MCC) is a rare, highly aggressive, neuroendocrine cutaneous tumor. The incidence of MCC is growing worldwide, and the disease-related mortality is about three-fold higher than melanoma.
Enrica Teresa Tanda, Enrica Teresa Tanda, Agostina Lagodin d’Amato, Agostina Lagodin d’Amato, Giovanni Rossi, Giovanni Rossi, Elena Croce, Elena Croce, Andrea Boutros, Andrea Boutros, Federica Cecchi, Francesco Spagnolo, Paola Queirolo   +12 more
doaj   +1 more source

Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: a real−world retrospective study

Frontiers in Immunology, 2023
ObjectivesThe treatment of locally advanced oral or oropharyngeal squamous cell carcinoma (LAOOPSCC) is surgery and radiotherapy or chemoradiotherapy but with unsatisfactory survival rate.
Wen-Jie Wu, Wen-Jie Wu, Wen-Jie Wu, Qian Liu, Qian Liu, Qian Liu, Pu-Gen An, Pu-Gen An, Pu-Gen An, Lin Wang, Lin Wang, Lin Wang, Jian-Yun Zhang, Jian-Yun Zhang, Jian-Yun Zhang, Yan Chen, Yan Chen, Yan Chen, Tong Zhang, Jie Zhang, Jie Zhang, Jie Zhang   +21 more
doaj   +1 more source

Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art

Cancer Communications, 2021
Lung cancer mortality has decreased over the past decade and can be partly attributed to advances in targeted therapy and immunotherapy. Immune checkpoint inhibitors (ICIs) have rapidly evolved from investigational drugs to standard of care for the ...
Jin Kang, Chao Zhang, Wen‐Zhao Zhong
doaj   +1 more source

PD-1 blockade in neoadjuvant setting of DNA mismatch repair-deficient/microsatellite instability-high colorectal cancer

OncoImmunology, 2020
Background: Although PD-1 blockade has significantly improved the survival of metastatic colorectal cancer with DNA Mismatch Repair-Deficient/Microsatellite Instability-High (MSI-H), the data on neoadjuvant setting is limited.
Ding-Xin Liu, Dan-Dan Li, Wan He, Chuan-Feng Ke, Wu Jiang, Jing-Hua Tang, Ling-Heng Kong, Yuan Li, Qiao-Qi Sui, Bin-Yi Xiao, Wei-Rong Li, Zhi-Gang Hong, Rui-Hua Xu, Zhi-Zhong Pan, Xiao-Shi Zhang, Pei-Rong Ding   +15 more
doaj   +1 more source

A multicenter phase II trial of neoadjuvant letrozole plus low‐dose cyclophosphamide in postmenopausal patients with estrogen receptor‐positive breast cancer (JBCRG‐07): therapeutic efficacy and clinical implications of circulating endothelial cells

Cancer Medicine, 2018
Neoadjuvant endocrine therapy has been reported to decrease tumor size, which leads to increased breast conservation rates. To improve the clinical response, metronomic chemotherapy with endocrine therapy is a promising strategy.
Takayuki Ueno, Norikazu Masuda, Shunji Kamigaki, Takashi Morimoto, Futoshi Akiyama, Masafumi Kurosumi, Hitoshi Tsuda, Yoshiki Mikami, Sunao Tanaka, Satoshi Morita, Masakazu Toi   +10 more
doaj   +1 more source

Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study

Frontiers in Oncology, 2021
PurposeNeoadjuvant radiotherapy (NeoRT) improves tumor local control and facilitates tumor resection in many cancers. Some clinical studies demonstrated that both timing of surgery and RT schedule influence tumor dissemination, and subsequently patient ...
François Lallemand, François Lallemand, François Lallemand, Natacha Leroi, Silvia Blacher, Mohamed Ali Bahri, Evelyne Balteau, Philippe Coucke, Agnès Noël, Alain Plenevaux, Philippe Martinive, Philippe Martinive   +11 more
doaj   +1 more source